Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome

Blood

Volumn 105, Issue 9, 2005, Pages 3528-3534

  Craven, Sarah E ^a   French, Dorothy ^a   Ye, Weilan ^a   De Sauvage, Frederic ^a   Rosenthal, Arnon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; GLUTAMIC ACID; GLYCINE; MORPHOLINE DERIVATIVE; PROTEIN HSPA9B; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD CELL; CYTOPENIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPLASIA; EMBRYO; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MITOCHONDRIAL RESPIRATION; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; ZEBRA FISH;

EID: 18244401639     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1089     Document Type: Article

References (58)

1. Kurzrock R. Myelodysplastic syndrome overview. Semin Hematol. 2002;39(suppl 2):18-25.
2. Vergilio J-A, Bagg A. Myelodysplastic syndromes: contemporary biologic concepts and emerging diagnostic approaches. Am J Clin Pathol. 2003;119:358-377.
3. Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M. Apoptosis and prognostic factors in myelodysplastic syndromes. Leuk Lymphoma 2002;43:257-260.
4. Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986;4:325-345.
5. Pedersen-Bjergaard J, Phillip P, Larsen SO, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood. 1990;76:1083-1091.
6. Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeioid leukemia: the University of Chicago series. Blood. 2003;102:43-52.
7. Bernasconi P, Alessandrino EP, Boni M, et al. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. Am J Hematol. 1994;46:270-277.
8. Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia. 2002;16:2366-2378.
9. Boultwood J, Fidler C, Strickson AJ, et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood. 2002;99:4638-4641.
10. Liu TX, Zhou Y, Kanki, JP, et al. Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies. Proc Natl Acad Sci USA. 2002;99:6136-6141.
11. Korrigan SK, Arbieva ZH, Xie HY, et al. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor in malignant myeloid disorders on 5q31. Blood. 2000;95:2372-2377.
12. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482-1488.
13. Gattermann N. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res. 1999;24:141-151.
14. Cohen AM, Alexandrova S, Bessler H, et al. Ultrastructural observations in bone marrow cells of 26 patients with myelodysplastic syndromes. Leuk Lymphoma. 1997;27:165-172.
15. van de Loosdrecht AA, Brada SJL, Blom NR, et al. Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. Leuk Res. 2001;25:385-393.
16. Dror Y. The role of mitochondrial-mediated apoptosis in a myelodysplastic syndrome secondary to congenital deletion of the short arm of chromosome 4. Exp Hematol. 2003;31:211-217.
17. Boudard D, Sordet O, Vasselon, C, et al. Expression and activity of caspase 1 and 3 in myelodysplastic syndromes. Leukemia. 2000;14:2045-2051.
18. Tehranchi R, Fadeel B, Forsblom A-M, et al. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood. 2003;101:1080-1086.
19. Reddy PL, Shetty VT, Dutt D, et al. Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes. Br J Haematol. 2002;116:564-575.
20. Shin MG, Kajigaya S, Levin BC, Young NS. Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood. 2003;101:3118-3125.
21. Orkin SH, Zon LI. Genetics of erythropoiesis: induced mutations in mice and zebrafish. Annu Rev Genet. 1997;31:33-60.
22. Galloway JL, Zon LI. Ontogeny of hematopoiesis: examining the emergence of hematopoietic cells in the vertebrate embryo. Curr Topics Dev Biol. 2003;53:139-158.
23. Weinstein BM, Schier AF, Abdelilah S, et al. Hematopoietic mutations in the zebrafish. Development 1996;123:303-309.
24. Ransom DG, Haffter P, Odenthal J, et al. Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development. 1996;123:311-319.
25. Brownlie A, Donovan A, Pratt SJ, et al. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet. 1998;20:244-250.
26. Childs S, Weinstein BM, Mohideen M-APK, et al. Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria. Curr Biol. 2000;10:1001-1004.
27. Rithedech KN, Cronkite EP, Bond VP. Advantages of the CBA mouse in leukemogenesis research. Blood Cells Mol Dis. 1999;25;38-45.
28. Benito AI, Bryant E, Loken MR, et al. NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Leuk Res. 2003;27:425-436.
29. Westerfield M. The Zebrafish Book. Eugene, OR: University of Oregon Press; 1993.
30. Kimmel CB, Ballard WW, Kimmel SR, Ullman B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253-310.
31. Quo S, Wilson SW, Cooke S, Chitnis AB, Driever W, Rosenthal A. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev Biol. 1999;208:473-487.
32. Furutani-Seiki M, Jiang Y-J, Brand M, et al. Neural degeneration mutants in the zebrafish, Danio rerio. Development. 1996;123:229-239.
33. Burkholder WF, Zhao X, Zhu X, Hendrickson WA, Gragerov A, Gottesman ME. Mutations in the C-terminal fragment of DnaK affecting peptide binding. Proc Natl Acad Sci USA. 1996;93:10632-10637.
34. Bennett CM, Kanki JP, Rhodes J, et al. Myelopoiesis in the zebrafish, Danio rerio. Blood. 2001;98:643-651.
35. Davidson AJ, Zon LI. The 'definitive' (and 'primitive') guide to zebrafish hematopoiesis. Oncogene. 2004;23:7233-7246.
36. Orkin SH, Zon LI. Genetics of erythropoiesis: induced mutations in mice and zebrafish. Annu Rev Genet. 1997;31:33-60.
37. Thompson MA, Ransom DG, Pratt SJ, et al. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev Biol. 1998;197:248-269.
38. Craig E, Kramer J, Kosic-Smithers J. SSC1, a member of the 70kDa heat shock protein multigene family of Saccaromyces cerevisiae is essential for growth. Proc Natl Acad Sci USA. 1987;84:4156-4160.
39. Kawai A, Nishikawa S, Hirata A, Endo T. Loss of the mitochondria Hsp70 functions causes aggregation of mitochondria in yeast cells. J Cell Sci. 2001;114:3565-3574.
40. Wadhwa R, Taira K, Kaul SC. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones. 2002;7:309-316
41. Droge W. Free radical in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
42. James AM, Murphy MP. How mitochondrial damage affects cell function. J Biomed Sci. 2002;9:475-487.
43. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta. 1998;1366:53-67.
44. Liu L, Trimarchi JR, Smith PJS, Keefe DL. Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell. 2002;1:40-46.
45. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal. 2002;4:405-414.
46. Ryter SW, Choi AMK. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal. 2002;4:749-758.
47. Zhu X, Zhao X, Burkholder WF, et al. Structural analysis of substrate binding by the molecular chaperone DnaK. Science. 1996;272:1606-1614.
48. Orsini R, Migliaccio E, Moroni M, et al. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem. 2004;279:25689-25695.
49. Kang P-J, Ostermann J, Shilling J, Neupert W, Craig EA, Pfanner N. Requirement for hsp70 in the mitochondrial matrix for translocation and folding of precursor proteins. Nature. 1990;348:137-143.
50. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292-2302.
51. Kalev-Zylinska ML, Horsfield JA, Flores MVC, et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development. 2002;129:2015-2030.
52. Xie H, Hu Z, Chyna B, Horrigan SK, Westbrook CA. Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31. Leukemia. 2000;14:2128-2134.
53. Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol. 2003;4:1238-1246.
54. Kokoszka JE, Coskun P, Esposito LA, Wallace DC. Increased mitochondrial oxidative stress in the Sod2(+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA. 2001;98:2278-2283.
55. Parker JC. Commentary: human mitochondrial cytopathies. Ann Clin Lab Sci. 2000;30:159-162.
56. Schon EA, Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J Clin Invest. 2003;111:303-312.
57. Rotig A, Colonna M, Bonnefont JP, et al. Mitochondrial DNA deletOns in Pearson's marrow/pancreas syndrome. Lancet. 1989;1:902-903.
58. Friedman JS, Rebel VI, Derby R, et al. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med. 2001;193:925-934.